Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACM Research, Inc. Director's Dealing 2022

Mar 11, 2022

31514_dirs_2022-03-11_59f68d11-e372-4d97-a219-f5244d2a3a14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACM Research, Inc. (ACMR)
CIK: 0001680062
Period of Report: 2022-03-09

Reporting Person: Dun Haiping (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-09 Class A Common Stock M 12269 $1.5 Acquired 309568 Direct
2022-03-09 Class A Common Stock S 1200 $80.48 Disposed 308368 Direct
2022-03-09 Class A Common Stock S 8069 $82.11 Disposed 300299 Direct
2022-03-09 Class A Common Stock S 3000 $82.66 Disposed 297299 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-09 Stock Option $1.5 M 12269 Disposed 2025-05-01 Class A Common Stock (231) Direct

Footnotes

F1: On March 9, 2022, the reporting person exercised a previously issued stock option to purchase 12,269 shares of Class A Common Stock of the Issuer.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.99 to $80.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6) to this Form 4.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.49 to $82.49, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.54 to $82.83, inclusive.

F6: The option vested and became exercisable as to 41,666 shares on May 1, 2016 and the remaining 125,001 shares vested and became exercisable in equal monthly installments over the following 36 months.